Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Arteries of the Head and Neck01:26

Arteries of the Head and Neck

3.6K
The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
3.6K
Veins of Head and Neck01:19

Veins of Head and Neck

5.8K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.8K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Vaccinations01:51

Vaccinations

51.9K
Overview
51.9K
Muscles of the Anterior Neck01:26

Muscles of the Anterior Neck

4.9K
The anterior neck muscles are the group of muscles covering the front part of the neck. These muscles are classified into three subgroups. The first one is the superficial muscles, the most visible muscles in the front of the neck. It includes the platysma and sternocleidomastoid. The second group is the suprahyoid muscles, located above the hyoid bone. This group comprises the digastric, mylohyoid, geniohyoid, and stylohyoid. Lastly, the infrahyoid muscles are found below the hyoid bone and...
4.9K
What is the Immune System?01:38

What is the Immune System?

132.7K
Overview
132.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splicing of HPV16 E6 promotes aggressive invasion in oropharyngeal cancer via endocytosis of E-cadherin.

bioRxiv : the preprint server for biology·2025
Same author

Nerve Types and Classification of Neurons Innervating Oral Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Increased Nerve Density Adversely Affects Outcome in Oral Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023
Same author

Spatial and Transcriptomic Analysis of Perineural Invasion in Oral Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same author

Impact of Nodal Metastases in HPV-Negative Oropharyngeal Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2022
Same journal

Gold Nanoparticles Enhance the Antibacterial and Osteogenic Properties of Polyetheretherketone.

Journal of dental research·2026
Same journal

Periodontitis-Aggravated Diabetic Kidney Disease with Altered Glycolysis.

Journal of dental research·2026
Same journal

Response to Letter to Editor: "Estimating the Individualized Effect of Tooth Extraction before Radiotherapy on Osteoradionecrosis Using Causal Machine Learning".

Journal of dental research·2026
Same journal

Reorienting Oral Health Promotion through Systems Thinking.

Journal of dental research·2026
Same journal

<i>Porphyromonas gingivalis</i>-Induced NETs Mediate Neuroinflammation via TLR4 Activation.

Journal of dental research·2026
Same journal

Oral Burden of Sjögren Disease: A Systematic Review and Meta-analysis.

Journal of dental research·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

8.4K

Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.

Y S Tan1,2, K Sansanaphongpricha3, M E P Prince2,4

  • 11 Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.

Journal of Dental Research
|March 14, 2018
PubMed
Summary
This summary is machine-generated.

Immune checkpoint receptor (ICR) blockade shows promise for head and neck squamous cell carcinoma (HNSCC), but resistance is common. Cancer vaccines can prime the immune system to enhance ICR inhibitor efficacy in HNSCC treatment.

Keywords:
immunizationimmunomodulationimmunotherapymouth neoplasmspapillomavirus infectionstumor escape

More Related Videos

Porcine As a Training Module for Head and Neck Microvascular Reconstruction
07:43

Porcine As a Training Module for Head and Neck Microvascular Reconstruction

Published on: September 29, 2018

8.2K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.4K

Related Experiment Videos

Last Updated: Feb 13, 2026

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

8.4K
Porcine As a Training Module for Head and Neck Microvascular Reconstruction
07:43

Porcine As a Training Module for Head and Neck Microvascular Reconstruction

Published on: September 29, 2018

8.2K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.4K

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Monoclonal antibodies targeting immune checkpoint receptors (ICRs) are approved for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
  • Effective response to ICR blockade depends on pre-existing tumor-specific T cells within the tumor microenvironment (TME).
  • Approximately 85% of HNSCC patients exhibit resistance to ICR blockade, necessitating strategies to overcome immune escape.

Purpose of the Study:

  • To review HNSCC immune evasion mechanisms.
  • To discuss advancements in HNSCC vaccines.
  • To identify challenges limiting cancer vaccine efficacy in HNSCC.

Main Methods:

  • Review of scientific literature on HNSCC immunology, ICR blockade, and cancer vaccines.
  • Analysis of immune evasion strategies in HNSCC.
  • Evaluation of the role of cancer vaccines in combination with ICR inhibitors.

Main Results:

  • ICR blockade reinvigorates exhausted CD8+ T cells but faces significant resistance in HNSCC.
  • Cancer vaccines can bypass the immunosuppressive TME, activate antigen-presenting cells (APCs), and expand tumor-specific T cells.
  • Vaccine-induced immune priming can create effector cells that synergize with ICR inhibitors.

Conclusions:

  • Cancer vaccines represent a promising priming strategy to enhance the efficacy of ICR inhibitors in HNSCC.
  • Overcoming HNSCC immune escape requires understanding evasion mechanisms and optimizing vaccine-based combinatorial approaches.
  • Further research is needed to address current challenges and improve the clinical efficacy of cancer vaccines in HNSCC.